268 related articles for article (PubMed ID: 11965544)
21. Epigenetic inactivation of RASSF1a in uveal melanoma.
Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.
Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J
Clin Cancer Res; 2002 Jul; 8(7):2362-8. PubMed ID: 12114441
[TBL] [Abstract][Full Text] [Related]
23. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
[TBL] [Abstract][Full Text] [Related]
24. Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.
Li Y; Chen Z
Cancer Lett; 2004 Jun; 209(1):75-85. PubMed ID: 15145523
[TBL] [Abstract][Full Text] [Related]
25. FNBP2 gene on human chromosome 1q32.1 encodes ARHGAP family protein with FCH, FBH, RhoGAP and SH3 domains.
Katoh M; Katoh M
Int J Mol Med; 2003 Jun; 11(6):791-7. PubMed ID: 12736724
[TBL] [Abstract][Full Text] [Related]
26. [Methylation of the putative tumor suppressor gene, RASSF1A, in primary cervical tumors].
Maliukova AV; Loginov VI; Khodyrev DS; Kadyrova EL; Pronina IV; Ivanova TA; Kiselev FL; Zabarovskiĭ NP; Braga EA
Mol Biol (Mosk); 2004; 38(6):1005-13. PubMed ID: 15612586
[TBL] [Abstract][Full Text] [Related]
27. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
28. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.
Hesson LB; Wilson R; Morton D; Adams C; Walker M; Maher ER; Latif F
Oncogene; 2005 Jun; 24(24):3987-94. PubMed ID: 15806169
[TBL] [Abstract][Full Text] [Related]
29. A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3.
Timmer T; Terpstra P; van den Berg A; Veldhuis PM; Ter Elst A; Voutsinas G; Hulsbeek MM; Draaijers TG; Looman MW; Kok K; Naylor SL; Buys CH
Eur J Hum Genet; 1999; 7(4):478-86. PubMed ID: 10352938
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of KAT, a novel gene preferentially expressed in several human cancer cell lines.
Wenzel K; Felix SB; Flachmeier C; Heere P; Schulze W; Grunewald I; Pankow H; Hewelt A; Scherneck S; Bauer D; Hoehe MR
Biol Chem; 2003 May; 384(5):763-75. PubMed ID: 12817473
[TBL] [Abstract][Full Text] [Related]
31. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3.
Daigo Y; Nishiwaki T; Kawasoe T; Tamari M; Tsuchiya E; Nakamura Y
Cancer Res; 1999 Apr; 59(8):1966-72. PubMed ID: 10213508
[TBL] [Abstract][Full Text] [Related]
32. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
33. [Expression of different RASSF1 transcripts and its clinical significance in lung carcinoma].
Shao K; He J; Cheng BC; Xiao ZX; Zhang DC; Huang W; Zhang CY; Zhou F; Xiong MH; Tang HJ; Shi SS; Mu BD
Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):149-52. PubMed ID: 12795841
[TBL] [Abstract][Full Text] [Related]
34. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22.
MacGrogan D; Levy A; Bova GS; Isaacs WB; Bookstein R
Genomics; 1996 Jul; 35(1):55-65. PubMed ID: 8661104
[TBL] [Abstract][Full Text] [Related]
35. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
[TBL] [Abstract][Full Text] [Related]
36. Frequent hypermethylation of the RASSF1A gene in prostate cancer.
Liu L; Yoon JH; Dammann R; Pfeifer GP
Oncogene; 2002 Oct; 21(44):6835-40. PubMed ID: 12360410
[TBL] [Abstract][Full Text] [Related]
37. LAPSER1: a novel candidate tumor suppressor gene from 10q24.3.
Cabeza-Arvelaiz Y; Thompson TC; Sepulveda JL; Chinault AC
Oncogene; 2001 Oct; 20(46):6707-17. PubMed ID: 11709705
[TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
[TBL] [Abstract][Full Text] [Related]
39. Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways.
Ikeda M; Hirabayashi S; Fujiwara N; Mori H; Kawata A; Iida J; Bao Y; Sato Y; Iida T; Sugimura H; Hata Y
Exp Cell Res; 2007 Apr; 313(7):1484-95. PubMed ID: 17367779
[TBL] [Abstract][Full Text] [Related]
40. RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family.
Eckfeld K; Hesson L; Vos MD; Bieche I; Latif F; Clark GJ
Cancer Res; 2004 Dec; 64(23):8688-93. PubMed ID: 15574778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
